Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43689 | 1.00 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL24699834 | 0.95 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL330951 | 0.88 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL26610 | 0.86 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL1136251 | 0.81 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL9323923 | 0.80 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL26012 | 0.80 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL5460574 | 0.80 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL11103013 | 0.80 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL1982615 | 0.80 | ALDH1A1 (0.46) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10308619-B2 | Substituted triazines and a method for producing same | COVESTRO DEUTSCHLAND AG (DE) | 2019-06-04 | — | — | US | disclosed |
| US-20180186758-A1 | SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME | COVESTRO DEUTSCHLAND AG (DE) | 2018-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180186758-A1 | SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME | CYP4Z1, TYR, DHPS | ALDH1A1 440/4885 |
| US-10308619-B2 | Substituted triazines and a method for producing same | CYP4Z1, TYR, DHPS | ALDH1A1 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.